Innovative Gene Therapy for Sickle Cell Anemia

Front

What is the new gene therapy for sickle cell anemia called?

Back

Lovotibeglogene autotemcel.

Front

Who was the first patient cured of sickle cell anemia using the new gene therapy?

Back

Sebastien Beauzile, a 21-year-old from New York.

Front

What does the new gene therapy do to blood stem cells?

Back

It modifies them to produce HbAT87Q, reducing sickling and improving blood flow.

Front

When was lovotibeglogene autotemcel approved by the FDA?

Back

December 8, 2023.

Front

What is the cost of the lovotibeglogene autotemcel treatment?

Back

Approximately $3.1 million per treatment.

Front

What is sickle cell disease (SCD)?

Back

A group of inherited disorders that affect hemoglobin, causing red blood cells to become sickle-shaped.

Front

Which populations are primarily affected by SCD?

Back

Black and Hispanic individuals.

Front

What is the standard treatment for SCD before gene therapy?

Back

Symptom management using hydroxyurea, L-glutamine, painkillers, and crizanlizumab-tmca.

Front

What is the success rate of the new gene therapy in clinical trials?

Back

Complete resolution of symptoms within 6 to 18 months in 88% of trial participants.

Front

What is the main barrier to accessing the new gene therapy?

Back

The high cost of treatment.